David Melnick
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 19
- Pneumonia and Respiratory Infections 9
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
- Co-authors
- Tova Meshulam (6 shared papers)Amy N. Schilling (3 shared papers)Vincent H. Tam (3 shared papers)R Sullivan (4 shared papers)Elizabeth A. Coyle (2 shared papers)Harry L. Malech (7 shared papers)Shádi Neshat (1 shared paper)Keith Poole (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (13 papers)Open Forum Infectious Diseases (8 papers)The Journal of Immunology (6 papers)Journal of Biological Chemistry (3 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
David Melnick
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 106
- Applied Microbiology and Biotechnology 187
- Molecular Medicine 467
- Pharmacology 572
- Infectious Diseases 475
- Epidemiology 544
Countries citing papers authored by David Melnick
This map shows the geographic impact of David Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Melnick more than expected).
Fields of papers citing papers by David Melnick
This network shows the impact of papers produced by David Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Melnick. The network helps show where David Melnick may publish in the future.
Co-authors
The 25 scholars most cited alongside David Melnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 171 | |
| 2 | 2018 | 157 | |
| 3 | 2012 | 136 | |
| 4 | 1987 | 133 | |
| 5 | 2011 | 103 | |
| 6 | 1988 | 98 | |
| 7 | 2013 | 74 | |
| 8 | 2005 | 71 | |
| 9 | 1992 | 67 | |
| 10 | 2014 | 64 | |
| 11 | 2022 | 58 | |
| 12 | 2019 | 57 | |
| 13 | 1986 | 55 | |
| 14 | 1985 | 43 | |
| 15 | 2021 | 41 | |
| 16 | 1992 | 40 | |
| 17 | 2019 | 39 | |
| 18 | 2011 | 39 | |
| 19 | 2019 | 38 | |
| 20 | 2021 | 34 |
About David Melnick
David Melnick is a scholar working on Epidemiology, Pharmacology, Molecular Biology, Infectious Diseases and Molecular Medicine, having authored 55 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (10 papers), Pneumonia and Respiratory Infections (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), S100 Proteins and Annexins (5 papers), Tuberculosis Research and Epidemiology (5 papers), Nosocomial Infections in ICU (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (187 citations), Molecular Medicine (467 citations), Pharmacology (572 citations), Infectious Diseases (475 citations) and Epidemiology (544 citations). David Melnick has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Tova Meshulam, Amy N. Schilling, Vincent H. Tam, R Sullivan, Elizabeth A. Coyle, Harry L. Malech, Shádi Neshat, Keith Poole, Richard D. Diamond and Thomas P. Lodise. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, The Journal of Immunology, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.